Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.MiddleBrook Pharmaceuticals, a developer of anti-infective products, has appointed Lord Blyth as its new vice chairman of the board of directors.
Subscribe to our email newsletter
Mr Blyth has also been retained as a consultant. In this capacity he will provide strategic guidance in late-stage development and commercialization tactics. Mr Blyth has recently retired from his role as chairman of Diageo, which he held since July 2000.
John Thievon, president and CEO of MiddleBrook, said: “I am extremely pleased to have James join our board of directors as vice chairman, and I look forward to working with him to ensure the future success of MiddleBrook.”